Bank of New York Mellon Corp Sells 108,047 Shares of HCA Healthcare, Inc. $HCA

Bank of New York Mellon Corp lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,149,837 shares of the company’s stock after selling 108,047 shares during the quarter. Bank of New York Mellon Corp’s holdings in HCA Healthcare were worth $440,503,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. ORG Partners LLC grew its holdings in HCA Healthcare by 27.9% during the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after acquiring an additional 31 shares during the last quarter. Avantax Advisory Services Inc. grew its holdings in HCA Healthcare by 0.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after acquiring an additional 32 shares during the last quarter. Glenview Trust co lifted its position in HCA Healthcare by 2.3% during the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock valued at $501,000 after purchasing an additional 32 shares during the period. Horizon Investments LLC lifted its position in HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after purchasing an additional 33 shares during the period. Finally, Sivia Capital Partners LLC lifted its position in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the period. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on HCA shares. Zacks Research upgraded shares of HCA Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 29th. Stephens upped their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. Robert W. Baird increased their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. JPMorgan Chase & Co. increased their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a research report on Monday, August 4th. Finally, Bank of America increased their price target on shares of HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a research report on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $473.53.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $460.84 on Tuesday. The company has a market capitalization of $107.83 billion, a P/E ratio of 17.81, a price-to-earnings-growth ratio of 1.38 and a beta of 1.40. The company’s 50 day moving average price is $422.26 and its two-hundred day moving average price is $388.13. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $478.19.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period last year, the company posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.